VRNIX | VSTSX | VRNIX / VSTSX | |
Total Expense Ratio | 0.06 | 0.01 | 600% |
Annual Report Gross Expense Ratio | 0.06 | 0.01 | 600% |
Fund Existence | 15 years | 9 years | - |
Gain YTD | 1.803 | 1.376 | 131% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.39B | 1.82T | 0% |
Annual Yield % from dividends | 1.23 | 1.29 | 95% |
Returns for 1 year | 10.51 | 10.09 | 104% |
Returns for 3 years | 59.49 | 57.70 | 103% |
Returns for 5 years | 94.27 | 91.51 | 103% |
Returns for 10 years | 178.89 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CSHZX | 12.42 | 0.07 | +0.57% |
NYLI Cushing® MLP Premier Class I | |||
HLHIX | 27.50 | -0.20 | -0.72% |
Virtus KAR Health Sciences Inst | |||
CWGCX | 67.87 | -0.73 | -1.06% |
American Funds Capital World Gr&Inc C | |||
GQIRX | 46.88 | -0.60 | -1.26% |
Goldman Sachs US Tax-Managed Eq Inv | |||
ICMPX | 17.57 | -0.31 | -1.73% |
Lazard International Quality Gr Instl |